A citation-based method for searching scientific literature

Ege T Kavalali, Lisa M Monteggia. Am J Psychiatry 2012
Times Cited: 171



Elena Nosyreva, Kristen Szabla, Anita E Autry, Alexey G Ryazanov, Lisa M Monteggia, Ege T Kavalali. J Neurosci 2013
Times Cited: 175




List of shared articles



Times cited

BDNF signaling in context: From synaptic regulation to psychiatric disorders.
Camille S Wang, Ege T Kavalali, Lisa M Monteggia. Cell 2022
24


Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice.
Radhika Rawat, Elif Tunc-Ozcan, Tammy L McGuire, Chian-Yu Peng, John A Kessler. Nat Commun 2022
3

A key requirement for synaptic Reelin signaling in ketamine-mediated behavioral and synaptic action.
Ji-Woon Kim, Joachim Herz, Ege T Kavalali, Lisa M Monteggia. Proc Natl Acad Sci U S A 2021
7

A synaptic locus for TrkB signaling underlying ketamine rapid antidepressant action.
Pei-Yi Lin, Z Zack Ma, Melissa Mahgoub, Ege T Kavalali, Lisa M Monteggia. Cell Rep 2021
13

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.
Lily R Aleksandrova, Anthony G Phillips. Trends Pharmacol Sci 2021
20



The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
Kanzo Suzuki, Lisa M Monteggia. Adv Pharmacol 2020
23

(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions.
Panos Zanos, Jaclyn N Highland, Brent W Stewart, Polymnia Georgiou, Carleigh E Jenne, Jacqueline Lovett, Patrick J Morris, Craig J Thomas, Ruin Moaddel, Carlos A Zarate,[...]. Proc Natl Acad Sci U S A 2019
73


Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice.
Amanda M Dossat, Katherine N Wright, Caroline E Strong, Mohamed Kabbaj. Neuropharmacology 2018
40


Calcium/Calmodulin-Dependent Protein Kinase II and Eukaryotic Elongation Factor 2 Kinase Pathways Mediate the Antidepressant Action of Ketamine.
Chinnakkaruppan Adaikkan, Elham Taha, Iliana Barrera, Orit David, Kobi Rosenblum. Biol Psychiatry 2018
40

Presynaptic origins of distinct modes of neurotransmitter release.
Natali L Chanaday, Ege T Kavalali. Curr Opin Neurobiol 2018
43



Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice.
Anna E Martin, Douglas A Schober, Alexander Nikolayev, Vladimir V Tolstikov, Wesley H Anderson, Richard E Higgs, Ming-Shang Kuo, Anastasia Laksmanan, John T Catlow, Xia Li,[...]. CNS Neurol Disord Drug Targets 2017
18

Pushing the threshold: How NMDAR antagonists induce homeostasis through protein synthesis to remedy depression.
Kimberly F Raab-Graham, Emily R Workman, Sanjeev Namjoshi, Farr Niere. Brain Res 2016
9

Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
Kristian Gaarn du Jardin, Heidi Kaastrup Müller, Betina Elfving, Elena Dale, Gregers Wegener, Connie Sanchez. Prog Neuropsychopharmacol Biol Psychiatry 2016
36